These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3712786)

  • 1. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents].
    Watanabe S; Igarashi S; Ichida T
    Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 3. Gingival hyperplasia and diphenylhydantoin.
    Ciancio SG; Yaffe SJ; Catz CC
    J Periodontol; 1972 Jul; 43(7):411-4. PubMed ID: 4504524
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study.
    Pihlstrom BL; Carlson JF; Smith QT; Bastien SA; Keenan KM
    J Periodontol; 1980 Jun; 51(6):311-7. PubMed ID: 6930469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between gingival hyperplasia and transfer of phenytoin to saliva and serum].
    Bostanci H; Aksoy N; Timlioğlu O
    Ankara Univ Hekim Fak Derg; 1988 May; 15(2):193-6. PubMed ID: 3271157
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model.
    Staple PH; Reed MJ; Mashimo PA
    J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin induced gingival overgrowth in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Murphy T; Best H
    J Clin Periodontol; 1984 Apr; 11(4):242-53. PubMed ID: 6584450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin-induced depression of salivary IgA and gingival hyperplasia.
    Aarli JA
    Epilepsia; 1976 Sep; 17(3):283-91. PubMed ID: 976219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva monitoring of anticonvulsants.
    Reynolds F; Knott C
    J Clin Chem Clin Biochem; 1989 Apr; 27(4):226-7. PubMed ID: 2738523
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
    Thomason JM; Seymour RA; Rawlins MD
    Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mixed salivary calcium and inorganic phosphorus, the rate of saliva excretion and the caries resistance of the teeth during of the mineralization period in children].
    Tokueva LI
    Stomatologiia (Mosk); 1983; 62(1):62-4. PubMed ID: 6219475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenytoin and gingival hyperplasia].
    Bostanci H; Aksoy N; Aydin N
    Ankara Univ Hekim Fak Derg; 1987 Sep; 14(3):313-6. PubMed ID: 3507874
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715.
    Morisaki I; Mihara J; Kato K; Kitamura K; Adachi C; Sobue S; Hamada S
    Arch Oral Biol; 1990; 35(9):753-8. PubMed ID: 2151111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gingival hyperplasia caused by Diphedan].
    Szekeresné Rudas L; Flerkóné Bárdos V
    Fogorv Sz; 1967 Jan; 60(1):16-20. PubMed ID: 5227710
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical course and histological evaluation of hydantoin-induced gingival hyperplasia].
    Bollobás E
    Fogorv Sz; 1986 Apr; 79(4):103-8. PubMed ID: 3457711
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.